1DII,
University of Texas, Houston, TX, United States; 2Neurosurgery,
Baylor College of Medicine, Houston, TX, United States

mild traumatic brain injury (mTBI) affects millions of
people each year. A treatment is unknown. He we present a potential therapeutic
agent, eryrhropoietin, which has been shown to be beneficial in other brain
injuries asTBI or global ischemia. We
used MRI, especially DTI, to quantify the effects of erythropoietin on mTBI.